P soriasis is chronic inflammatory skin condition with an autoimmune pathogenetic component and a strong, but complex, genetic inheritance (1, 2) . The estimated prevalence of psoriasis in the western world is 3-4% in adults and 0.4-1.37% in children and adole scents (henceforth "children") (3) (4) (5) (6) (7) . The prevalence rate increases approximately linearly, from 0.12% at an age of 1 year to 1.24% at 18 years of age (3) . Incidence of psoriasis is bimodal, with a large peak at 16-22 years and a smaller peak at 57-60 years, probably reflecting different disease entities (8) . The disease can be debilita ting for patients due to pruritus and visible disfiguration resulting from presence of red plaques with silvery scales, in turn leading to decreased quality of life (9) . In addition, patients with psoriasis have an increased risk of several comorbidities, such as cardiovascular disease, metabolic syndrome, and psoriatic arthritis (10) (11) (12) (13) (14) (15) (16) (17) (18) .
Studies suggest that some of the comorbidities and as sociated risk factors that are seen in adults with psoriasis may also be present in children with psoriasis. Indeed, studies have suggested increased presence of arterial hypertension, metabolic syndrome, and autoimmune diseases, including rheumatoid arthritis and Crohn's disease, in paediatric psoriasis (3, (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) .
Autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease (IBD), have a profound negative effect on quality of life (29, 30) . They are there fore a potential additional disease burden to keep in mind when treating patients with psoriasis. Autoimmune diseases display a heightened immune response against the person's own tissue, cells, and cellular components, such as DNA, keratin, or, for psoriasis, a melanocytic autoantigen. A recent study confirmed that psoriasis shares genetic susceptibility loci with a range of autoim mune diseases including IBD (2, 31) . In order to further examine the risk of concomitant autoimmune disease and clustering of autoimmune diseases in children with psoriasis compared with healthy controls, we conducted a crosssectional study using the total paediatric popula tion in Denmark.
METHODS

Population
All inhabitants under the age of 18 years who were alive and resident in Denmark on 31 December 2012 were identified. All residents in Denmark are assigned a unique personal 10-digit iden tification number at birth or immigration, which enables linkage on the individual level between different Danish administrative registers. This study used data from the Danish Civil Registration System, the Danish National Patient Register, and the Danish Na tional Prescription Registry. Data on age, sex, vital-and migration status were available from the Danish Civil Registration System (32 1, 5 , Gunnar H. GISLASON [2] [3] [4] , Claus ZACHARIAE 1 in accordance with the Anatomical Therapeutic Chemical (ATC) classification system (34) .
Lifetime psoriasis was defined as having either an ICD code of psoriasis (ICD-10 L40, not including L40.5 arthropathic pso riasis) or by the second claimed prescription of topical vitamin D analogues (ATC code D05AX). Topical vitamin D analogues are the favoured first-line psoriasis treatment in Denmark and are registered exclusively for psoriasis. The use of prescription claims allowed us to also identify milder psoriasis cases not treated in a hospital setting. The second claimed prescription was used to ensure persistent medical therapy. Children with lifetime psoriasis were compared, with respect to lifetime diagnosis of 9 selected autoimmune diseases, with children without psoriasis.
Information on the lifeexperience of the 9 autoimmune diseases in the Danish National Patient Register was traced. The 9 diseases of interest were a priori selected based on paediatric relevance ( Table I) . We decided to group together psoriatic arthritis, juvenile psoriatic arthritis, and juvenile idiopathic arthritis (JIA) since their clinical signs and symptoms may be difficult to distinguish in young patients (35) .
Statistical analysis
For baseline characteristics means and standard deviations (SDs) were used to describe continuous variables, and frequencies and percentages for categorical variables. Logistic regression was used to estimate crude and adjusted odds ratios (ORs) (in which age, sex, and healthcare consumption were considered) for the correlation between a psoriasis diagnosis and other autoimmune diseases. Healthcare consumption was defined as the number of dermatology visits. A significance level of 0.05 was used and results were reported with 95% confidence intervals (95% CIs) where applicable. All analyses were performed using SAS statis tical software version 9.4 (SAS Institute Inc., Cary, NC, USA) and STATA software version 13.0 (StataCorp, College Station, TX, USA).
This crosssectional study of childhood coexistence of psoriasis and autoimmune diseases was undertaken in accordance with the "Strengthening the Reporting of Observational Studies in Epide miology (STROBE)" statement (36) 
RESULTS
A total of 1,925 children with a diagnosis of psoriasis and 1,194,712 children without such a diagnosis (Table  II) were identified. The majority of the study population was of Danish descent. Children with psoriasis were more likely to be female (54.7% vs. 48.8%). Adjusting for age, sex, and healthcare consumption showed similar results as when adjusting for age and sex only. The presented results below are adjusted for age, sex and healthcare consumption, which give the most conservative esti (Table III) .
DISCUSSION
In our study, psoriatic arthritis, rheumatoid arthritis, vitiligo, autoimmune thyroiditis, and unspecified IBD were significantly associated with psoriasis in children. Furthermore, children with psoriasis had a significantly higher risk of having multiple concurring autoimmune diseases compared with children without psoriasis. Our results suggest that psoriasis in children is associated with some, but not all, of the autoimmune diseases pre viously shown in adults (10, 37) . Only 2 previous studies in children have included narrow ungrouped selections of autoimmune diseases, but both studies lacked adjust ments for confounding factors including age, sex, and healthcare consumption (3, 28) .
Adjustment for respectively age and sex, and age, sex, and healthcare consumption yielded similar results with the latter being the more conservative. As expected, psoriatic arthritis was strongly associated with psoriasis, but also rheumatoid arthritis was significantly associa ted with psoriasis, which confirms previous findings in children and adults (3, 10) . Children with psoriasis had an increased risk of vitiligo, which is in agreement with observations in adults (10, 37) . However, a study in children could not show this (28) . One reason for the observed association between psoriasis and vitiligo could be due to misclassification of healed depigmented psoriasis lesions, but this explanation seems less likely, since the diagnosis of vitiligo in our study is based on a hospital diagnosis and is therefore probably given by a trained dermatologist. Conversely, vitiligo may be iden tified more often, since the children with psoriasis are seen by dermatologists. We did not find the individual IBDs (Crohn's disease and ulcerative colitis) associated with psoriasis, even though previous studies in adults have shown this (10, 38) . Previous studies in children have shown conflicting results. In one study Crohn's disease was found to be more prevalent in children with psoriasis, while another paediatric study failed to show a significant association between the respective IBDs and psoriasis (3, 28) . In contrast to previous studies, we did not find a significant association between coeliac disease and psoriasis (39, 40) . One possible explanation for the abovementioned discrepancies could be that our study population is inherently young. The children have therefore not reached an age where the prevalence of the studied autoimmune diseases has reached a level where a possible association can be shown. This could either be because the diseases have not yet developed or due to a delayed hospital diagnosis based on still unspecific symptoms. For example, in the case of IBD the incidence rate does not peak until 15-29 years of age, with the gra dient of the curve increasing sharply to this point (41) . The study by Augustin et al. (3), showing a significant association between Crohn's disease and psoriasis in children, did not control for any potential confounding factors; consequently, their results were similar to our unadjusted results. A modest, but significant, association was found between psoriasis and autoimmune thyroiditis in children, even though such an association has not been found in adults with psoriasis (42, 43) . In our study, we did not find any association between psoriasis and type 1 diabetes; an observation in accordance with previous findings from adults with psoriasis (10) . The previous studies on the association between psoriasis and diabe tes in children have focused either on type 2 diabetes or diabetes in general with no discrimination between type 1 and type 2 diabetes (3, 28, 44) . Interestingly, the results of the current study suggest that children with psoriasis in general have a higher risk of having autoimmune di seases. This clustering of autoimmune disease has also been shown in adults with psoriasis and is supported by the fact that many of these autoimmune diseases share genetic loci (10, 31, 45) . The results of the current study also suggest that psoriasis is associated with an even higher risk of having multiple autoimmune diseases, and this has not been proven in adults (10) .
The current study has several strengths; it was based on a large nationwide register; we were able to include also milder psoriasis cases via vitamin D analogue usage; and it was possible to adjust for important confounders. All inhabitants in Denmark have equal access to taxsupported healthcare without charge, including treatment in hospitalbased settings and by general practitioners. Selection bias was thus minimized. Although vitamin D analogues are not officially recommended for use in children, a recent consensus paper confirmed that practicing dermatologists agree on and recommend the use of topical vitamin D analogues as a first-choice in paediatric psoriasis (34) . A recent review also demon strated that topical vitamin D analogues are efficacious and generally safe for paediatric use (35) . Due to the www.medicaljournals.se/acta natural history of many autoimmune diseases, it may be difficult to determine the exact time of disease onset, e.g. patients may have had symptoms for years before seeking medical attention or before a correct diagnosis is assigned. Thus, we opted for a crosssectional study de sign as this does not include temporal assessment. All the investigated associations were found to be significant in the unadjusted form, which emphasizes the importance of considering confounding factors. In particular, healthcare consumption among patients with psoriasis could bias the observed comorbidity, due to an increased number of doctor's visits compared with the general population. This is supported by the fact that all results are more conservative when healthcare consumption is included in the model (Table III) . The current study is limited by its descriptive nature and offers no causal explanations. The provided data are very much dependent on correct clinical diagnosis, but the included autoimmune diseases are most likely diagnosed by hospital specialists in re levant fields, e.g. arthritis by rheumatologists, IBD by gastroenterologists, etc. The decision to group together psoriatic arthritis, juvenile psoriatic arthritis, and JIA on the basis of diagnostic difficulties is supported by the fact that a subanalysis showed that some children with psoriasis had a diagnosis of JIA, while some children without psoriasis had a diagnosis of psoriatic arthritis (data not shown). Furthermore, clinical presentation of the aforementioned paediatric diseases can be very similar and thus difficult to distinguish (35) . Since Crohn's disease and ulcerative colitis are more easily distinguished through different diagnostic methods (e.g. endoscopy and histology) we decided not to group them together in a single IBD entity. Furthermore, the respec tive diseases have different genetic and environmental risk factors (46) . The prevalence of psoriasis in children is relatively low, and most of the autoimmune diseases studied are themselves rare. Consequently, the absolute number of observed children with concomitant autoim mune diseases is small. This yields broad confidence in tervals, and the results should be interpreted accordingly. The absolute numbers of cases in the psoriasis group for both autoimmune thyroiditis and the categories of IBD are between 3 and 4. Therefore, just one case could be decisive. With regards to generalizability, our study is predominantly in children of Danish descent, and the results on clustering of autoimmune disease are in agree ment with previous findings in adults (10) .
Conclusion
Autoimmune diseases are known to cluster and can have a severe effect on quality of life. This study shows that children and adolescents with psoriasis are at increased risk of having one or more selected autoimmune diseases compared with the general population. Although many of these conditions remain rare, clinicians should keep these associations in mind when treating psoriasis in children, as they may add to the total disease burden. In particular, focus on extracutaneous symptoms is advised.
